4-Bromo-2-(trifluoromethyl)benzonitrile, 99.0%, 10g

(E)-3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylic acid, 95.0%, 250mg

Tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione, 97.0%, 25g

(1R)-1-(2-FLUORO-5-METHOXYPHENYL)ETHYLAMINE, 98%, 250mg

4-Fluoro-2-methyl-3-nitrobenzoic acid, 97.0%, 50mg

2,5-Dimethyl-1-(4-nitrophenyl)-1H-pyrrole, 98%, 25g

Imidazolo[1,5-a]pyridine, 95.0%, 25g

N,N-Diphenyl-2-naphthylamine>98.0%(GC)5g

4-Chloro-2-methylsulfanylpyrimidine, 98.0%, 10g

GC capillary column ROTI®Cap-1701, 60 m, 0.25 mm, 0.25 µm, 1 Piece(s)

1-((4-Hydrazinylbenzyl)sulfonyl)pyrrolidine hydrochloride, 95.0%, 1g

2,3,5-Trichlorophenylboronic acid, 95.0%, 10g

Tetramethylammonium Hydroxide Pentahydrate>97.0%(T)100g